Please Wait.....
Report
NA Transfection Reagents and Equipment Market - Industry Trends and Forecast to 2030
Market Report I 2023-02-01 I 187 Pages I Data Bridge Market Research
North America transfection reagents and equipment market is projected to register a substantial CAGR of 9.9% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
North America Transfection Reagents and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagents and Equipment, Stable Transfection Reagents, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (By Type and By Industry), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2030
Some of the drivers that boost transfection reagents and equipment market's growth are as follows:
- Rise in the prevalence of chronic diseases
- Growing demand of chimeric genes
Market Players:
Some of the major players operating in the North America transfection reagents and equipment market are:
- Mirus Bio LLC.
- Promega Corporation
- Polyplus Transfection
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Lonza
- MaxCyte, Inc.
- Altogen Biosystems
- SBS Genetech
- FUJIFILM Irvine Scientific (A Subsidiary of FUJIFILM Holdings Corporation)
- Avanti Polar Lipids (A Subsidiary of Croda International Plc)
- Cytiva
- Geno Technology Inc., USA
- R&D Systems, Inc.
- Takara Bio Inc.
- Thermofisher Scientific Inc.
- OriGene Technologies, Inc.
- Applied Biological Materials Inc. (abm)
- Beckman Coulter, Inc. (A Subsidiary of Danaher)
- SignaGen Laboratories
- Genlantis Inc.
- Ginkgo Bioworks
TABLE OF CONTENTS
1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 OVERVIEW OF THE NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET 18
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 22
2 MARKET SEGMENTATION 28
2.1 MARKETS COVERED 28
2.2 GEOGRAPHICAL SCOPE 29
2.3 YEARS CONSIDERED FOR THE STUDY 30
2.4 CURRENCY AND PRICING 30
2.5 DBMR TRIPOD DATA VALIDATION MODEL 31
2.6 MULTIVARIATE MODELLING 34
2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE 34
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
2.9 DBMR MARKET POSITION GRID 36
2.10 MARKET APPLICATION COVERAGE GRID 37
2.11 VENDOR SHARE ANALYSIS 38
2.12 SECONDARY SOURCES 39
2.13 ASSUMPTIONS 39
3 EXECUTIVE SUMMARY 40
4 PREMIUM INSIGHT 43
4.1 PESTEL 44
4.2 PORTER'S FIVE FORCES MODEL 45
5 INDUSTRY INSIGHTS: 46
6 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, REGULATIONS 47
6.1 EUROPEAN UNION REGULATORY SCENARIO 47
6.2 U.S. REGULATORY SCENARIO 48
6.3 JAPAN REGULATORY SCENARIO 48
6.4 CHINA REGULATORY SCENARIO 49
7 MARKET OVERVIEW 51
7.1 DRIVERS 53
7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES 53
7.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS 54
7.1.3 GROWING DEMAND FOR CHIMERIC GENES 54
7.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH 55
7.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS 55
7.2 RESTRAINTS 56
7.2.1 HIGH COST OF TRANSFECTION PRODUCTS 56
7.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS 56
7.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE 57
7.3 OPPORTUNITIES 57
7.3.1 EXPLORATION OF EMERGING MARKET 57
7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 58
7.3.3 SURGING LEVEL OF INVESTMENT 59
7.4 CHALLENGES 59
7.4.1 LONG APPROVAL PROCEDURE 59
7.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS-ASSOCIATED TRANSFECTION 60
7.4.3 LACK OF TRAINED PROFESSIONALS 61
8 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS 62
8.1 OVERVIEW 63
8.2 REAGENTS & KITS 66
8.3 INSTRUMENTS 67
9 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE 69
9.1 OVERVIEW 70
9.2 RESEARCH 73
9.3 PRECLINICAL 73
9.4 CLINICAL PHASES 74
9.5 COMMERCIAL 75
10 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE 77
10.1 OVERVIEW 78
10.2 TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT 81
10.3 STABLE TRANSECTION REAGENTS AND EQUIPMENT 81
11 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY METHODS 83
11.1 OVERVIEW 84
11.2 NON-VIRAL METHODS 87
11.3 VIRAL METHODS 87
12 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE 89
12.1 OVERVIEW 90
12.2 PLASMID DNA 92
12.3 SMALL INTERFERING RNA (SIRNA) 93
12.4 PROTEINS 94
12.5 DNA OLIGONUCLEOTIDES 95
12.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS) 96
12.7 OTHERS 96
13 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM 98
13.1 OVERVIEW 99
13.2 MAMMALIAN CELLS 101
13.3 PLANTS 102
13.4 FUNGI 103
13.5 VIRUS 104
13.6 BACTERIA 105
14 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY APPLICATION 106
14.1 OVERVIEW 107
14.2 IN VITRO APPLICATION 109
14.2.1 IN VIVO APPLICATION 111
14.2.2 BIOPRODUCTION 112
14.2.3 OTHERS 112
14.2.4 SYNTHETIC BIOLOGY 113
14.2.5 AGRICULTURE 113
14.2.6 OTHERS 113
15 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER 114
15.1 OVERVIEW 115
15.2 BIOPHARMA 118
15.3 CROS 118
15.4 CMOS/CDMOS 119
15.5 ACADEMIA 120
15.6 HOSPITALS 121
15.7 CLINICAL LABS 122
15.8 OTHERS 123
16 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL 124
16.1 OVERVIEW 125
16.2 DIRECT TENDER 128
16.3 RETAIL SALES 129
16.4 OTHERS 130
17 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION 131
17.1 NORTH AMERICA 132
17.1.1 U.S. 137
17.1.2 CANADA 137
17.1.3 MEXICO 137
18 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, COMPANY LANDSCAPE 138
18.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 138
19 SWOT ANALYSIS 139
20 COMPANY PROFILE 140
20.1 THERMO FISHER SCIENTIFIC INC. 140
20.1.1 COMPANY SNAPSHOT 140
20.1.2 REVENUE ANALYSIS 140
20.1.3 COMPANY SHARE ANALYSIS 141
20.1.4 PRODUCT PORTFOLIO 141
20.1.5 RECENT DEVELOPMENT 142
20.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD) 143
20.2.1 COMPANY SNAPSHOT 143
20.2.2 REVENUE ANALYSIS 143
20.2.3 COMPANY SHARE ANALYSIS 144
20.2.4 PRODUCT PORTFOLIO 144
20.2.5 RECENT DEVELOPMENT 145
20.3 PROMEGA CORPORATION 146
20.3.1 COMPANY SNAPSHOT 146
20.3.2 COMPANY SHARE ANALYSIS 146
20.3.3 PRODUCT PORTFOLIO 147
20.3.4 RECENT DEVELOPMENT 147
20.4 TAKARA BIO INC. 148
20.4.1 COMPANY SNAPSHOT 148
20.4.2 REVENUE ANALYSIS 148
20.4.3 COMPANY SHARE ANALYSIS 149
20.4.4 PRODUCT PORTFOLIO 149
20.4.5 RECENT DEVELOPMENT 149
20.5 BIO-RAD LABORATORIES, INC. 150
20.5.1 COMPANY SNAPSHOT 150
20.5.2 REVENUE ANANLYSIS 150
20.5.3 COMPANY SHARE ANALYSIS 151
20.5.4 PRODUCT PORTFOLIO 151
20.5.5 RECENT DEVELOPMENT 152
20.6 ALTOGEN BIOSYSTEMS 153
20.6.1 COMPANY SNAPSHOT 153
20.6.2 PRODUCT PORTFOLIO 153
20.6.3 RECENT DEVELOPMENT 154
20.7 APPLIED BIOLOGICAL MATERIALS INC. (ABM) 155
20.7.1 COMPANY SNAPSHOT 155
20.7.2 PRODUCT PORTFOLIO 155
20.7.3 RECENT DEVELOPMENT 155
20.8 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC) 156
20.8.1 COMPANY SNAPSHOT 156
20.8.2 REVENUE ANALYSIS 156
20.8.3 PRODUCT PORTFOLIO 157
20.8.4 RECENT DEVELOPMENT 157
20.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER) 158
20.9.1 COMPANY SNAPSHOT 158
20.9.2 PRODUCT PORTFOLIO 158
20.9.3 RECENT DEVELOPMENT 158
20.10 CYTIVA 159
20.10.1 COMPANY SNAPSHOT 159
20.10.2 PRODUCT PORTFOLIO 159
20.10.3 RECENT DEVELOPMENT 159
20.11 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION) 160
20.11.1 COMPANY SNAPSHOT 160
20.11.2 REVENUE ANANLYSIS 160
20.11.3 PRODUCT PORTFOLIO 161
20.11.4 RECENT DEVELOPMENT 161
20.12 GENLANTIS INC. 162
20.12.1 COMPANY SNAPSHOT 162
20.12.2 PRODUCT PORTFOLIO 162
20.12.3 RECENT DEVELOPMENT 162
20.13 GENO TECHNOLOGY INC., USA 163
20.13.1 COMPANY SNAPSHOT 163
20.13.2 PRODUCT PORTFOLIO 163
20.13.3 RECENT DEVELOPMENT 163
20.14 GINKGO BIOWORKS 164
20.14.1 COMPANY SNAPSHOT 164
20.14.2 PRODUCT PORTFOLIO 164
20.14.3 RECENT DEVELOPMENTS 164
20.15 LONZA 165
20.15.1 COMPANY SNAPSHOT 165
20.15.2 REVENUE ANANLYSIS 165
20.15.3 PRODUCT PORTFOLIO 166
20.15.4 RECENT DEVELOPMENT 166
20.16 MAXCYTE, INC. 167
20.16.1 COMPANY SNAPSHOT 167
20.16.2 REVENUE ANALYSIS 167
20.16.3 PRODUCT PORTFOLIO 168
20.16.4 RECENT DEVELOPMENT 168
20.17 MERCK KGAA 169
20.17.1 COMPANY SNAPSHOT 169
20.17.2 REVENUE ANALYSIS 169
20.17.3 PRODUCT PORTFOLIO 170
20.17.4 RECENT DEVELOPMENT 170
20.18 MIRUS BIO LLC. 171
20.18.1 COMPANY SNAPSHOT 171
20.18.2 PRODUCT PORTFOLIO 171
20.18.3 RECENT DEVELOPMENT 171
20.19 ORIGENE TECHNOLOGIES, INC. 173
20.19.1 COMPANY SNAPSHOT 173
20.19.2 PRODUCT PORTFOLIO 173
20.19.3 RECENT DEVELOPMENT 173
20.20 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.) 174
20.20.1 COMPANY SNAPSHOT 174
20.20.2 REVENUE ANALYSIS 174
20.20.3 PRODUCT PORTFOLIO 175
20.20.4 RECENT DEVELOPMENT 175
20.21 POLYPLUS TRANSFECTION 176
20.21.1 COMPANY SNAPSHOT 176
20.21.2 PRODUCT PORTFOLIO 176
20.21.3 RECENT DEVELOPMENT 176
20.22 R&D SYSTEMS, INC. 178
20.22.1 COMPANY SNAPSHOT 178
20.22.2 PRODUCT PORTFOLIO 178
20.22.3 RECENT DEVELOPMENT 178
20.23 SBS GENETECH 179
20.23.1 COMPANY SNAPSHOT 179
20.23.2 PRODUCT PORTFOLIO 179
20.23.3 RECENT DEVELOPMENT 179
20.24 SIGNAGEN LABORATORIES 180
20.24.1 COMPANY SNAPSHOT 180
20.24.2 PRODUCT PORTFOLIO 180
20.24.3 RECENT DEVELOPMENT 180
21 QUESTIONNAIRE 182
22 RELATED REPORTS 187
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security